PKCβI mediates the inhibition of P2Y receptor-induced inositol phosphate formation in endothelial cells

British Journal of Pharmacology

Volumn 127, Issue 8, 1999, Pages 1908-1914

  Chen, Bing C ^a   Lin, Wan W ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

2MeSATP; Endothelium; P2 receptors; PI turnover; PKC I; Receptor up regulation; UTP

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; 2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; 2 METHYLTHIOADENOSINE TRIPHOSPHATE; ANTISENSE OLIGONUCLEOTIDE; FLUORIDE SODIUM; INOSITOL PHOSPHATE; LY 379196; MEMBRANE ENZYME; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHATIDYLINOSITIDE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; PURINE P2 RECEPTOR; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG; URIDINE TRIPHOSPHATE; 2-METHYLTHIO-ATP; ADENOSINE TRIPHOSPHATE; DRUG DERIVATIVE; NUCLEOTIDE; PHORBOL DERIVATIVE; PURINE P2Y1 RECEPTOR; PURINE P2Y2 RECEPTOR;

ANIMAL CELL; ARTERY ENDOTHELIUM; ARTICLE; CONTROLLED STUDY; CYTOSOL; DOSE RESPONSE; ENDOTHELIUM CELL; ENZYME ACTIVATION; GENETIC TRANSFECTION; IMMUNOBLOTTING; INTRACELLULAR TRANSPORT; ISOTOPE LABELING; NEGATIVE FEEDBACK; NONHUMAN; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; PULMONARY ARTERY; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; BIOSYNTHESIS; CATTLE; CELL CULTURE; CYTOLOGY; DRUG EFFECT; GENETICS; METABOLISM; VASCULAR ENDOTHELIUM;

ADENOSINE TRIPHOSPHATE; ANIMALS; CATTLE; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; INOSITOL PHOSPHATES; PHORBOLS; PROTEIN KINASE C; PULMONARY ARTERY; RECEPTORS, PURINERGIC P2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THIONUCLEOTIDES; URIDINE TRIPHOSPHATE;

EID: 0032588150     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702727     Document Type: Article

References (38)

1. Beltman, J., McCormick, F. & Cook, S.J. (1996). The selective protein kinase C inhibitor, Ro 31-8220, inhibits mitogen-activated protein kinase phosphatase-1 (MKP-1) expression, induced c-Jun expression, and activates Jun N-terminal kinase. J. Biol. Chem., 171, 27018-27024.
2. 2 receptors: multiple sites and multiple receptors. Trends Pharmacol. Sci., 19, 99-107.
3. 2 purinoceptors: from molecular biology to functional responses. Trends Pharmacol. Sci., 16, 133-139.
4. 2 purinoceptors on vascular endothelial cells: physiological significance and transduction mechanisms. Trends Pharmacol. Sci., 11, 34-37.
5. Born, G.V.R. & Kratzer, M.A.A. (1984). Source and concentration of extracellular adenosine triphosphate during haemostasis in rats, rabbits and man. J. Physiol. Lond., 354, 419-429.
6. Boutherin-Falson, O., Reuse, S., Dumont, J.E. & Boey-Naems, J.-M. (1990). Increased levels of c-fos and c-myc mRNA in ATP-stimulated endothelial cells. Biochem. Biophys. Res. Commun., 172, 306-312.
7. 2 purinoceptor-stimulated conversion of arginine to citrulline in bovine endothelial cells is reduced by inhibition of protein kinase C. Biochem. Pharmacol., 52, 1849-1854.
8. 2u purinoceptors in bovine pulmonary artery endothelial cells. J. Cardiovasc. Pharmacol., 28, 192-199.
9. 2 in endothelial cells. Eu. J. Pharmacol. (in press).
10. Chuang, D.-M. (1989). Neurotransmitter receptors and phosphoinosilide turnover. Ann. Rev. Pharmacol. Toxicol., 29, 71-110.
11. Communi, D. & Boeynaems, J.-M, (1997). Receptors responsive to extracellular pyrimidine nucleotides. Trends Pharmacol. Sci., 18, 83-86.
12. 2u receptors on aortic endothelial cells. Comparison of cell localization and signaling pathways. Circ. Res., 76, 191-198.
13. Darbon, J.M., Tournier, J.F., Tanber, J.P. & Bayard, F. (1986). Possible role of protein phosphorylation in the mitogenic effect of high density lipoproteins on cultured vascular endothelial cells. J. Biol. Chem., 261, 8002-8008.
14. Edwards, F.A., Gibb, A.J. & Colquhoun, D. (1992). ATP receptor mediated synaptic currents in the central nervous system. Nature, 359, 144-147.
15. Evans, R.J., Derkach, V. & Surprenant, A. (1992). ATP mediates fast synaptic transmission in mammalian neurons. Nature, 357, 503-505.
16. 2 receptors. Trends Pharmacol. Sci., 18, 79-82.
17. Hepler, J.R., Earp, H.S. & Harden, T.K. (1998). Long-term phorbol ester treatment down-regulates protein kinase C and sensitizes the phosphoinositide signaling pathway to hormone and growth factor stimulation: evidence for a role of protein kinase C in agonist-induced desensitization. J. Biol. Chem., 263, 7610-7619.
18. Jin, J., Rao Dasari, V., Sistare, F.D. & Kunapuli, S.P. (1998). Distribution of P2Y receptor subtypes on haematopoietic cells. Br. J. Pharmacol. 123, 789-794.
19. Lazarowski, E.R., Homolya, L., Boucher, R.C. & Harden, T.K. (1997). Direct demonstration of mechanically induced release of cellular UTP and its implication for uride nucleotide receptor activation. J. Biol. Chem., 272, 24348-24354.
20. Levesque, L., Dean, N.M., Sasmor, D.H. & Crooke, S.T. (1997). Antisense oligonucleotides targeting human protein kinase C-x inhibit phorbol ester-induced reduction of bradykinin-evoked calcium mobilization in A549 cells. Mol. Pharmacol., 51, 209-216.
21. Li, H., Oehrlein, S.A., Walleerath, T., Ihrig-Biedert, I., Wohlfart, P., Ulshfer, T., Jessen, T., Herget, T., Forstermann, U. & Kleinert, H. (1998). Activation of protein kinaseCα and/or ε enhances transcription of the human endothelial nitric oxide synthase gene. Mol. Pharmacol., 53, 630-637.
22. 2 and adenylyl cyclase by phorbol ester in RAW 264.7 macrophages. Br. J. Pharmacol., 125, 1601-1609.
23. Lin, W.W. & Chuang, D.M. (1992). Regulation of bradykinin-induced phosphoinositide turnover in cultured cerebellar astrocytes: possible role of protein kinase C. Neurochem. Int., 21, 573-579.
24. 2u-purinergic nucleotide receptor messenger RNA expression during in vitro differentiation of human myeloid leukocytes by phorbol esters or inflammatory activators. Mol. Pharmacol., 51, 97-108.
25. Martiny-Baron, G., Kazanietz, M.G., Mischak, H., Blumberg, P.M., Kochs, G., Hug, H., Marme, D. & Schachtele, C. (1993). Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J. Biol. Chem., 268, 9194-9197.
26. Mochly-Rosen, D. & Gordon, A.D. (1998). Anchoring proteins for protein kinase C: a means for isozyme selectivity. FASEB J., 12, 35-42.
27. Nishizuka, Y. (1984). The role of protein kinase C in cell surface signal transduction and tumor promotion. Nature, 308, 693-698.
28. Nishizuka, Y. (1992). Intracellulr signaling by hydrolysis of phospholipids and activation of protein kinase C. Science, 258, 607-614.
29. Nishizuka, Y. (1995). Protein kinase C and lipid signaling for sustained cellular responses. FASEB J., 9, 484-496.
30. North, R.A. & Barnard, E.A. (1997). Nucleotide receptors, Curr. Opin. Neurobiol., 7, 346-357.
31. Ohno, S., Kawasaki, H., IMAJOH, S. & Suzuki, K. (1987). Tissue-specific expression of three distinct types of rabbit protein kinase C. Nature, 325, 161-166.
32. Osipchuk, Y. & Cahalan, M. (1992). Cell-to-cell spread of calcium signals mediated by ATP receptors in mast cells. Nature, 359, 241-244.
33. 2u-purinoceptor-stimulated prostacyclin release. Br. J. Pharmacol., 118, 123-130.
34. 2-purinergic receptors on vascular endothelial cells: Transduction mechanisms. Ann. NY Acad. Sci., 603, 480-483.
35. 2y-purinoceptors and nucleotide receptors on bovine aortic endothelial cells. Br. J. Pharmacol., 111, 723-728.
36. Van Daele, P., Van Coevorden, A., Roger, P.P. & Boeynaems, J.-M. (1992). Effects of adenosine nucleotides on the proliferalion of aortic endothelial cells. Circ. Res., 70, 82-90.
37. 2y purinoceptors: expression in rat heart. J. Auto. Pharmacol., 16, 303-307.
38. 2+ entry by protein kinase C β. J. Biol. Chem., 270, 23887-23890.